SCHEDULE 13G FOR HEMISPHERX BIOPHARMA

Company

AIM ImmunoTech Inc.

Filed

February 9, 1999

Accession Number

0000884589-99-000079

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →